Pimavanserin for Irritability in Children and Adolescents With Autism Spectrum Disorder: Phase 2 Randomized Trial.
- DOI
- 10.1016/j.jaac.2026.05.007
- Published
- 2026 May 19
- Container
- Journal of the American Academy of Child and Adolescent Psychiatry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaac.2026.05.007,
title = {Pimavanserin for Irritability in Children and Adolescents With Autism Spectrum Disorder: Phase 2 Randomized Trial.},
author = {Bugarski-Kirola D and Hofbauer RK and Sameljak S and Marco EJ and Sumiła A and Darwish M and Ortiz S and Liu IY and Nunez R and Zhang PH and Arango C},
year = {2026},
journal = {Journal of the American Academy of Child and Adolescent Psychiatry},
doi = {10.1016/j.jaac.2026.05.007},
url = {https://doi.org/10.1016/j.jaac.2026.05.007}
}RIS
TY - JOUR TI - Pimavanserin for Irritability in Children and Adolescents With Autism Spectrum Disorder: Phase 2 Randomized Trial. AU - Bugarski-Kirola D AU - Hofbauer RK AU - Sameljak S AU - Marco EJ AU - Sumiła A AU - Darwish M AU - Ortiz S AU - Liu IY AU - Nunez R AU - Zhang PH AU - Arango C PY - 2026 JO - Journal of the American Academy of Child and Adolescent Psychiatry DO - 10.1016/j.jaac.2026.05.007 UR - https://doi.org/10.1016/j.jaac.2026.05.007 ER -
APA
D, B., RK, H., S, S., EJ, M., A, S., M, D., S, O., IY, L., R, N., PH, Z., & C, A. (2026). Pimavanserin for Irritability in Children and Adolescents With Autism Spectrum Disorder: Phase 2 Randomized Trial.. Journal of the American Academy of Child and Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2026.05.007
Source records
- pubmed · retrieved 2026-11-10T12:44:50.368Z